Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "N02BB02" (26)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Metamizole Sodium (N02BB02) 26 products
WHO-DDD
DrugBank.ca
IP
CI
Novalgin
‐
I
10 Tablet(s)
1.21
10.55
20 %
Tablets: Metamizolum Natricum Monohydricum 500 mg
Opella Healthcare
Switzerland AG
B / SL / SO
FB
G
IP
CI
Novalgin
‐
I
50 Tablet(s)
3.65
13.15
20 %
Tablets: Metamizolum Natricum Monohydricum 500 mg
Opella Healthcare
Switzerland AG
B / SL / SO
FB
G
IP
CI
Novalgin
10 ml
1.20
10.55
10 %
Drops: Metamizolum Natricum Monohydricum 500 mg/ml
Opella Healthcare
Switzerland AG
B / SL / SO
FB
G
IP
CI
Novalgin
20 ml
2.11
11.50
10 %
Drops: Metamizolum Natricum Monohydricum 500 mg/ml
Opella Healthcare
Switzerland AG
●
B / SL / SO
FB
G
IP
CI
Novalgin
100 ml
9.45
26.60
10 %
Drops: Metamizolum Natricum Monohydricum 500 mg/ml
Opella Healthcare
Switzerland AG
●
B / SL / SO
FB
G
IP
CI
Metamizol Spirig HC 500 mg
10 Tablet(s)
10.30
10 %
Tablets: Metamizolum Natricum Monohydricum 500 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Metamizol Spirig HC 500 mg
50 Tablet(s)
2.43
11.90
10 %
Tablets: Metamizolum Natricum Monohydricum 500 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Metamizol Spirig HC 500 mg
100 Tablet(s)
4.86
14.50
10 %
Tablets: Metamizolum Natricum Monohydricum 500 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Metamizol-Mepha 500 mg
10
10.30
10 %
Tablette: Metamizolum Natricum Monohydricum 500 mg
Mepha Pharma AG
●
B / SL / SG
FB
G
IP
CI
Metamizol-Mepha 500 mg
50
2.43
11.90
10 %
Tablette: Metamizolum Natricum Monohydricum 500 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Metamizol Spirig HC 500
mg/ml
20 ml
2.03
11.45
10 %
Tropfen zum Einnehmen: Metamizolum Natricum Monohydricum 500 mg/ml
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Metamizol Spirig HC 500
mg/ml
100 ml
8.03
25.15
10 %
Tropfen zum Einnehmen: Metamizolum Natricum Monohydricum 500 mg/ml
Spirig HealthCare AG
●
B / SL / SG
FB
G
IP
CI
Minalgin
10 1 ampoule(s) à 2 ml
3.49
13.05
10 %
Injection solution: Metamizolum Natricum Monohydricum 500 mg/ml
Streuli Pharma AG
●
B / SL
FB
G
IP
CI
Novalgin
10 1 ampoule(s) à 2 ml
3.49
13.05
10 %
Injection solution: Metamizolum Natricum Monohydricum 500 mg/ml
Opella Healthcare
Switzerland AG
B / SL
FB
G
IP
CI
Novalgin
5 1 ampoule(s) à 5 ml
3.23
12.75
10 %
Injection solution: Metamizolum Natricum Monohydricum 500 mg/ml
Opella Healthcare
Switzerland AG
B / SL
FB
G
IP
CI
Novalgin
5 suppositories
1.81
11.20
10 %
Suppositories: Metamizolum Natricum Monohydricum 1 g
Opella Healthcare
Switzerland AG
B / SL
FB
G
IP
CI
Minalgin
20 Tablet(s)
2.30
11.75
10 %
Tablets: Metamizolum Natricum Monohydricum 500 mg
Streuli Pharma AG
●
B / SL
FB
G
IP
CI
Minalgin
50
3.98
13.45
10 %
Tablets: Metamizolum Natricum Monohydricum 500 mg
Streuli Pharma AG
●
B / SL
FB
G
IP
CI
Minalgin
100 ml
10.25
27.50
10 %
Solution (oral): Metamizolum Natricum Monohydricum 500 mg/ml
Streuli Pharma AG
●
B / SL
FB
G
IP
CI
Minalgin
20 ml
2.60
12.05
10 %
Drops: Metamizolum Natricum Monohydricum 500 mg/ml
Streuli Pharma AG
B / SL
FB
G
IP
CI
Minalgin
100 ml
10.25
27.50
10 %
Drops: Metamizolum Natricum Monohydricum 500 mg/ml
Streuli Pharma AG
●
B / SL
FB
G
IP
Novaminsulfon Sintetica 500
mg/ml
10 1 ampoule(s) à 2 ml
PR
PR
k.A.
Injection solution: Metamizolum Natricum Monohydricum 500 mg/ml
Sintetica SA
B
FB
G
IP
Novaminsulfon Sintetica 500
mg/ml
10 1 ampoule(s) à 5 ml
PR
PR
k.A.
Injection solution: Metamizolum Natricum Monohydricum 500 mg/ml
Sintetica SA
B
FB
G
IP
CI
Metamizol Spirig HC 500 mg
20 Tablet(s)
PR
PR
k.A.
Tablets: Metamizolum Natricum Monohydricum 500 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Minalgin
100 Tablet(s)
PR
PR
k.A.
Tablets: Metamizolum Natricum Monohydricum 500 mg
Streuli Pharma AG
●
B
FB
G
IP
CI
Minalgin
1000
PR
PR
k.A.
Tablets: Metamizolum Natricum Monohydricum 500 mg
Streuli Pharma AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
